Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 Years

NCT01433926 · clinicaltrials.gov ↗
COMPLETED
Status
114
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Asociación para el Progreso de la Oncología en Málaga

Collaborators